Literature DB >> 6605369

Cleavage and inactivation of Factor IX by granulocyte elastase.

A Takaki, D L Enfield, A R Thompson.   

Abstract

Radioiodinated Factor IX was cleaved by a crude sonicate from leukocytes. In the absence of calcium, fragments of less than 15,000 mol wt were seen from reduced samples on gel electrophoresis. After digestion in 2 mM calcium, however, electrophoresis of reduced samples showed, in addition to low molecular weight fragments, protein bands corresponding in size to heavy and light chains of Factor XIa-activated Factor IX. The cleaving activity in leukocyte sonicates was inhibited by soybean trypsin inhibitor, but only to a small extent by aprotinin. Granulocyte elastase was isolated from purified polymorphonuclear leukocyte granules by affinity chromatography on soybean trypsin inhibitor-agarose and further chromatography on carboxymethyl cellulose. The purified fraction contained two isozymes on acidic gels which cleaved both an ester sensitive to elastase and radiolabeled Factor IX. These two activities were inhibited by elastase-specific chloromethyl ketone. The isolated protease fraction rapidly inactivated apparent Factor IX activity in a coagulant assay system. The degree of inactivation correlated with the amount of intact, radiolabeled Factor IX cleaved. As with the crude sonicate, generation of the larger heavy and light chain-sized fragments was dependent upon calcium. To assess directly the effect of elastase on Factor IX, an immunospecific, active site-directed assay was developed. In this assay, the sample was incubated with solid-phase antibody to Factor IX and the amount of activated product was detected as that which had complexed with radioiodinated antithrombin III. In this system, exposure of Factor IX to Factor XIa showed progressive increase in the ability to bind antithrombin III, whereas after elastase, Factor XIa was unable to generate antithrombin III binding. The elastase-degraded Factor IX did not inhibit activation of additional Factor IX in clotting assays. When Factor IXa was incubated with elastase, binding of antithrombin III was decreased, corresponding to appearance of low molecular weight fragments on parallel samples that were reduced and electrophoresed. These data are consistent with elastase inactivating Factor IX by cleaving bonds near, but distinct from, bonds cleaved by Factor XIa.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6605369      PMCID: PMC370459          DOI: 10.1172/JCI111130

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Effect of elastase-like and chymotrypsin-like neutral proteases from human granulocytes on isolated clotting factors.

Authors:  W Schmidt; R Egbring; K Havemann
Journal:  Thromb Res       Date:  1975-04       Impact factor: 3.944

2.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

3.  The use of p-nitrophenyl N-tert-butyloxycarbonyl-L-alaninate as substrate for elastase.

Authors:  L Visser; E R Blout
Journal:  Biochim Biophys Acta       Date:  1972-04-07

4.  Inactivation of bovine thrombin by nitrous acid.

Authors:  S Magnusson; T Hofmann
Journal:  Can J Biochem       Date:  1970-04

5.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

6.  Human leukocyte granule elastase: rapid isolation and characterization.

Authors:  R J Baugh; J Travis
Journal:  Biochemistry       Date:  1976-02-24       Impact factor: 3.162

7.  Inhibition of human factor IXa by human antithrombin.

Authors:  J S Rosenberg; P W McKenna; R D Rosenberg
Journal:  J Biol Chem       Date:  1975-12-10       Impact factor: 5.157

8.  Separation and characterization of human neutrophil granules.

Authors:  B C West; A S Rosenthal; N A Gelb; H R Kimball
Journal:  Am J Pathol       Date:  1974-10       Impact factor: 4.307

9.  The assay of the bromelains using N alpha-CBZ-L-lysine p-nitrophenyl ester and N-CBZ-glycine p-nitrophenyl ester as substrates.

Authors:  R M Silverstein
Journal:  Anal Biochem       Date:  1974-12       Impact factor: 3.365

10.  A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S.

Authors:  R G Di Scipio; M A Hermodson; S G Yates; E W Davie
Journal:  Biochemistry       Date:  1977-02-22       Impact factor: 3.162

View more
  5 in total

1.  Oxidative regulation of neutrophil elastase-alpha-1-proteinase inhibitor interactions.

Authors:  P J Ossanna; S T Test; N R Matheson; S Regiani; S J Weiss
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

2.  Proteolytic inactivation of human leukocyte elastase.

Authors:  R L Stein; J C Williams
Journal:  Experientia       Date:  1985-05-15

3.  Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leukocyte proteases and their major inhibitors.

Authors:  R Berling; A Borgström; K Ohlsson
Journal:  Int J Pancreatol       Date:  1998-08

4.  Granulocyte elastase cleaves human high molecular weight kininogen and destroys its clot-promoting activity.

Authors:  J Kleniewski; V Donaldson
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

Review 5.  Emerging and future therapies for hemophilia.

Authors:  Marcus E Carr; Bartholomew J Tortella
Journal:  J Blood Med       Date:  2015-09-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.